Literature DB >> 10197759

Cortistatin affects glutamate sensitivity in mouse hypothalamic neurons through activation of sst2 somatostatin receptor subtype.

A Vasilaki1, C Lanneau, P Dournaud, L De Lecea, R Gardette, J Epelbaum.   

Abstract

Cortistatin is a 14-residue putative neuropeptide with strong structural similarity to somatostatin. Even if it shares several biological properties with somatostatin, the effects of cortistatin on cortical electrical activity and sleep are opposite to those elicited by somatostatin. We recently demonstrated that somatostatin could modulate glutamate sensitivity, either positively through activation of the sstl receptor subtype, or negatively through activation of the sst2 receptor subtype in hypothalamic neurons in culture which express almost exclusively these two sst subtypes. Thus, in the present study we compared the effects of cortistatin and somatostatin in hypothalamic neurons in culture, in order to define the former peptide activity on both subtypes. We first determined that the affinities of cortistatin and somatostatin were similar on cloned rat sstl and sst2 receptor subtypes in transfected cells and hypothalamic neurons membranes. We then found that cortistatin, like somatostatin, depresses the glutamate response but, unlike somatostatin, never potentiates glutamate sensitivity in hypothalamic neurons. The observed effect of cortistatin is strongly suggestive of an activation of the somatostatin sst2 receptor subtype in hypothalamic neurons in culture.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10197759     DOI: 10.1016/s0306-4522(98)00413-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

1.  AMPA-sst2 somatostatin receptor interaction in rat hypothalamus requires activation of NMDA and/or metabotropic glutamate receptors and depends on intracellular calcium.

Authors:  Stéphane Peineau; Brigitte Potier; Florence Petit; Pascal Dournaud; Jacques Epelbaum; Robert Gardette
Journal:  J Physiol       Date:  2003-01-01       Impact factor: 5.182

2.  Cortistatin-14 inhibits cell proliferation of human thyroid carcinoma cell lines of both follicular and parafollicular origin.

Authors:  P Cassoni; G Muccioli; T Marrocco; M Volante; E Allia; E Ghigo; R Deghenghi; M Papotti
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

3.  Effect of somatostatin analogues on chemically induced ischaemia in the rat retina.

Authors:  Niki Mastrodimou; George N Lambrou; Kyriaki Thermos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-01-12       Impact factor: 3.000

4.  Effects of cortistatin-14 and somatostatin-14 on the endocrine response to hexarelin in humans.

Authors:  A Benso; C Gottero; F Prodam; C Gauna; S Destefanis; L Filtri; A J van der Lely; R Deghenghi; E Ghigo; F Broglio
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

5.  Parallel changes in gene expression in peripheral blood mononuclear cells and the brain after maternal separation in the mouse.

Authors:  Johan H van Heerden; Ana Conesa; Dan J Stein; David Montaner; Vivienne Russell; Nicola Illing
Journal:  BMC Res Notes       Date:  2009-09-25

Review 6.  Targeting the ghrelin receptor: orally active GHS and cortistatin analogs.

Authors:  Romano Deghenghi; Fabio Broglio; Mauro Papotti; Giampiero Muccioli; Ezio Ghigo
Journal:  Endocrine       Date:  2003-10       Impact factor: 3.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.